> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Magellan Resumes LeadCare II Distribution
- URL: https://www.fdaweb.com/magellan-resumes-leadcare-ii-distribution/
- Published: 2022-03-31T12:00:00.000Z
- Updated: 2026-09-14T17:38:56.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5151497

FDA says Magellan Diagnostics has resumed distribution of its LeadCare II product that was previously unavailable. The LeadCare Plus and LeadCare Ultra products are currently unavailable, an agency [update](https://www.fda.gov/medical-devices/medical-device-recalls/magellan-diagnostics-recalls-leadcare-ii-leadcare-plus-and-leadcare-ultra-blood-lead-tests-due-risk?ref=fdaweb.com) says.

FDA announced on 5/28/21 a Class I Magellan recall of its LeadCare II, LeadCare Plus, and LeadCare Ultra blood lead tests due to a significant risk of falsely low results.